drugset / Trial / NCT01409096
Study Using Pregnenolone to Treat Bipolar Depression
Phase 4
Completed
80 enrolled
University of Texas Southwestern Medical Center
Stanley Medical Research Institute · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Primary purpose of this study is to determine if pregnenolone supplementation is associated with greater improvement in depressive symptoms of patients with bipolar disorder. Also the study will explore possibilities of improving anxiety and manic symptoms as well as the patient's cognition.
Timeline
- Start
- 2010-03
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pregnenolone | Other / unclassified | 250 mg | — |